New NMR Technique Enables Direct Detection of Molecular Chirality
Researchers develop an NMR method to distinguish between enantiomers without the need for chiral agents
| News
A new nuclear magnetic resonance (NMR) technique now allows for the direct detection of molecular chirality, eliminating the need for additional chiral agents. The study presents a method that uses both electric and magnetic dipoles to differentiate between enantiomers – molecules that are mirror images of each other but cannot be superimposed. This innovation could streamline applications in drug discovery and materials science where chirality plays a critical role.
Chirality is particularly important in pharmaceuticals, as one enantiomer of a drug may be therapeutically beneficial, while its mirror image could be inactive or harmful. Traditionally, distinguishing enantiomers with NMR required the use of chiral solvating agents or derivatization, which can introduce complexity and potential inaccuracies in the analysis.
The new method utilizes a concept originally proposed by A.D. Buckingham, coupling electric and magnetic dipoles to detect chirality directly. The researchers – Sagar Wadhwa, Jan G. Korvink, and Dominique Buyens, all from the Institute of Microstructure Technology, Germany – developed a double-resonant radiofrequency (RF) NMR detector sensitive to both electric and magnetic dipoles. This detector allows for chiral discrimination in liquid-state NMR without chemical modifications or complex preparations.
The team’s approach relies on generating changes in magnetization trajectories by applying an RF electric field in conjunction with a magnetic pulse. This technique induces phase shifts in the NMR signals of enantiomers due to a parity-dependent tensor, leading to detectable differences in the free induction decay (FID) signals of mirror-image molecules.
In experimental applications, the researchers demonstrated the effectiveness of the technique on several chiral molecules, including 1,1,1-trifluoropropan-2-ol, ibuprofen, and thalidomide. The team successfully distinguished between the (S)- and (R)-enantiomers of ibuprofen, which have different pharmacological effects. The ability to measure these differences directly, without the need for external chiral agents, simplifies the analytical process.
This technique measures chiral signals in both racemic mixtures and pure enantiomers, with signal intensity corresponding to the enantiomeric excess of the sample. The researchers utilized liquid-state NMR alongside density functional theory (DFT) calculations to better understand the electric and magnetic interactions that generate these chirality-dependent signals.
Future work will focus on refining this method for broader use in fields such as chiral drug synthesis and biochemical analysis, where molecular chirality is crucial.
